Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.17% | 203.56 | 1.3% | $427.08m | |
| BIIB | Biogen Inc. | -0.93% | 225.60 | 1.3% | $388.53m | |
| GILD | Gilead Sciences, Inc. | -0.35% | 65.00 | 0.9% | $366.13m | |
| CELG | Celgene Corporation | 0.82% | 101.80 | 1.3% | $356.32m | |
| ILMN | Illumina, Inc. | 0.28% | 310.55 | 3.5% | $253.40m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.73% | 301.57 | 2.6% | $219.86m | |
| EXAS | Exact Sciences Corporation | -0.20% | 97.39 | 24.1% | $203.99m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.48% | 99.99 | 2.0% | $181.39m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.93% | 177.72 | 1.9% | $178.93m | |
| A | Agilent Technologies, Inc. | -0.47% | 74.92 | 1.6% | $143.96m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.81% | 87.44 | 14.6% | $138.15m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.06% | 67.90 | 4.3% | $95.86m | |
| SGEN | Seattle Genetics, Inc. | 2.48% | 85.94 | 6.2% | $90.55m | |
| NKTR | Nektar Therapeutics | 1.31% | 17.77 | 5.5% | $84.92m | |
| ALDR | Alder Biopharmaceuticals, Inc. | 0.16% | 18.90 | 10.2% | $83.36m |
Company Profile
Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities includes recruiting personnel, conducting research and development, including clinical trials, raising capital and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.